Tscan Therapeutics Inc (NASDAQ:TCRX)’s traded shares stood at 0.46 million during the last session, with the company’s beta value hitting 1.01. At the close of
Tscan Therapeutics Inc (NASDAQ:TCRX)’s traded shares stood at 0.19 million during the last session, with the company’s beta value hitting 0.97. At the close of
During the last session, Tscan Therapeutics Inc (NASDAQ:TCRX)’s traded shares were 0.27 million, with the beta value of the company hitting 0.98. At the end
Tscan Therapeutics Inc (NASDAQ:TCRX) has a beta value of 0.97 and has seen 1.18 million shares traded in the last trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne